Jiang DM, Hamilton RJ, Hansen AR. Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time . CUAJ [Internet]. 2020 Jan. 30 [cited 2024 Apr. 24];14(2):48-9. Available from: https://cuaj.ca/index.php/journal/article/view/6407